<DOC>
	<DOCNO>NCT01118897</DOCNO>
	<brief_summary>SUMMARY PROJECT TITLE : Concurrent chemo-radiation use Tomotherapy base IMRT locally advance Gallbladder Pancreatic cancer : A Phase II study SPECIFIC OBJECTIVES : Primary To assess radiological response dose escalate IMRT locally advance inoperable gallbladder pancreatic cancer . Secondary 1 . To assess resectability rate microscopic negative margin ( R0 ) . 2 . To assess acute late toxicity ( Number Participants Adverse Events Measure Safety Tolerability ) 3 . To study locoregional control patient undergo R0 resection 4 . To study overall survival DESIGN : Phase II study STUDY POPULATION : All patient age &gt; 18 year year diagnose non metastatic locally advanced inoperable gall bladder pancreatic cancer STUDY SIZE : 60 patient METHODOLOGY : Sixty case screen take study eligible take informed consent . Patients receive radiotherapy use Tomotherapy base IMRT concurrent chemotherapy Gemcitabine weekly . The response evaluate 6 week post chemoradiation operable undergo surgery , still inoperable metastatic receive palliative chemotherapy . PROJECT PERIOD : Total project period : 3 year Recruitment , Data collection : 2 year Complete analysis data : 1 year STUDY SITE : Tata memorial centre</brief_summary>
	<brief_title>Tomotherapy Locally Advanced Gallbladder Pancreatic Cancers</brief_title>
	<detailed_description>In gall bladder pancreatic cancer surgery main stay treatment , majority tumor inoperable virtue adjacent organ infiltration . In study , inoperable gallbladder pancreatic cancer patient treat high precision radiotherapy use Tomotherapy deliver high dose radiation along chemotherapy . It expect high dose precise radiotherapy along chemotherapy lead good symptom relief make tumor operable .</detailed_description>
	<mesh_term>Neoplasms</mesh_term>
	<mesh_term>Pancreatic Neoplasms</mesh_term>
	<mesh_term>Gallbladder Neoplasms</mesh_term>
	<criteria>1 . Inoperable locally advanced gall bladder pancreatic cancer virtue vascular encasement superior mesenteric artery ( SMA ) , celiac artery , hepatic artery , portal vein ( PV ) deep hilar invasion preclude R0 resection . 2 . Biopsy proven adenocarcinoma 3 . KPS &gt; = 70 4 . Age &gt; 18 year 5 . Medically fit chemotherapy 6 . Normal hematological , renal hepatic function ( Serum Bilirubin &lt; 3mg/dl ) 7 . No prior history treatment radiation chemotherapy . 8 . Patient willing reliable followup . Exclusion criteria 1 . Any malignancy site . 2 . Expected survival &lt; 3months . 3 . Severe comorbid condition ( Severe cardiac disorder , severe bronchial asthma , severely compromise liver function , psychological disorder ) 4 . Malignant ascitis . 5 . Distant metastasis clinical examination imaging/whole bodyPET scan .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>May 2010</verification_date>
	<keyword>Gall bladder</keyword>
	<keyword>Pancreatic cancer</keyword>
	<keyword>Tomotherapy</keyword>
</DOC>